Sarepta Therapeutics
SRPT
$116.55
Share price
-1.14%
Change (1 day)
-7.17%
Change (1 year)
Categories
Sarepta Therapeutics is an American medical research company dedicated to the discovery and development of precisely effective gene therapeutics for the treatment of rare neuromuscular diseases.
Number of shares outstanding for Sarepta Therapeutics (SRPT)
Number of shares outstanding as of April 2024 : 88,889,000
According to Sarepta Therapeutics 's latest financial reports and stock price the company's current number of shares outstanding is 88,889,000. At the end of 2023 the company had 88,889,000 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Shares outstanding history for Sarepta Therapeutics from 2012 to 2023
Shares Outstanding at the end of each year
| Year | Shares Outstanding | Change |
|---|---|---|
| 2023 | 88.88 M | 1.44% |
| 2022 | 87.62 M | 9.7% |
| 2021 | 79.88 M | 1.76% |
| 2020 | 78.5 M | 5.83% |
| 2019 | 74.17 M | 8.05% |
| 2018 | 68.65 M | 6.81% |
| 2017 | 64.27 M | 17.68% |
| 2016 | 54.61 M | 21.69% |
| 2015 | 44.88 M | 8.66% |
| 2014 | 41.3 M | 9.86% |
| 2013 | 37.59 M | 64.72% |
| 2012 | 22.82 M |
Shares Outstanding for similar companies or competitors
| Company | Shares Outstanding | differencediff. | Country |
|---|---|---|---|
 Gilead Sciences GILD | 1,248,000,000 | 1,304.00% | 🇺🇸 USA |
 PTC Therapeutics
PTCT | 75,377,997 | -15.20% | 🇺🇸 USA |
 Novavax NVAX | 103,429,000 | 16.36% | 🇺🇸 USA |
 Alnylam Pharmaceuticals
ALNY | 125,220,000 | 40.87% | 🇺🇸 USA |
 Insmed INSM | 142,899,000 | 60.76% | 🇺🇸 USA |
 BioCryst Pharmaceuticals
BCRX | 189,644,000 | 113.35% | 🇺🇸 USA |
 Avidity Biosciences RNA | 74,097,000 | -16.64% | 🇺🇸 USA |